Advice
In the absence of a submission from the holder of the marketing authorisation.
gonapeptyl depot is not recommended for use within NHS Scotland for the treatment of advanced, hormone-dependent prostate carcinoma.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- Gonapeptyl depot 3.75mg
- SMC ID:
- 269/06
- Indication:
- Advanced, hormone-dependent prostate carcinoma
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 May 2006